Trial Profile
Phase III Trial for Primary Radiotherapy With Single-Agent Cisplatin or Combination Chemotherapy in PET/CT Defined Poor-Prognostic Cervical Cancer Patients.
Status:
Recruiting
Phase of Trial:
Phase III
Latest Information Update: 24 Sep 2015
Price :
$35
*
At a glance
- Drugs Cisplatin (Primary) ; Gemcitabine (Primary)
- Indications Cervical cancer
- Focus Therapeutic Use
- 06 Jan 2010 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 17 Feb 2009 New trial record